Logo image of ANRG.CA

ANAERGIA INC-SUB VOTING SHR (ANRG.CA) Stock Fundamental Analysis

Canada - TSX:ANRG - CA03253E2069 - Common Stock

2.66 CAD
+0.04 (+1.53%)
Last: 9/19/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, ANRG scores 2 out of 10 in our fundamental rating. ANRG was compared to 24 industry peers in the Commercial Services & Supplies industry. ANRG may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ANRG is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ANRG had negative earnings in the past year.
ANRG had a negative operating cash flow in the past year.
ANRG had negative earnings in each of the past 5 years.
ANRG had negative operating cash flow in 4 of the past 5 years.
ANRG.CA Yearly Net Income VS EBIT VS OCF VS FCFANRG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

The Return On Assets of ANRG (-15.41%) is worse than 75.00% of its industry peers.
Industry RankSector Rank
ROA -15.41%
ROE N/A
ROIC N/A
ROA(3y)-30.26%
ROA(5y)-19.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ANRG.CA Yearly ROA, ROE, ROICANRG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

The Gross Margin of ANRG (25.70%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ANRG has remained more or less at the same level.
ANRG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.61%
GM growth 5Y-1.13%
ANRG.CA Yearly Profit, Operating, Gross MarginsANRG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

0

2. Health

2.1 Basic Checks

ANRG does not have a ROIC to compare to the WACC, probably because it is not profitable.
ANRG has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ANRG has been increased compared to 5 years ago.
The debt/assets ratio for ANRG is higher compared to a year ago.
ANRG.CA Yearly Shares OutstandingANRG.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
ANRG.CA Yearly Total Debt VS Total AssetsANRG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

ANRG has an Altman-Z score of -2.13. This is a bad value and indicates that ANRG is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ANRG (-2.13) is worse than 79.17% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.13
ROIC/WACCN/A
WACC7.75%
ANRG.CA Yearly LT Debt VS Equity VS FCFANRG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.91 indicates that ANRG may have some problems paying its short term obligations.
ANRG has a Current ratio of 0.91. This is in the lower half of the industry: ANRG underperforms 62.50% of its industry peers.
A Quick Ratio of 0.81 indicates that ANRG may have some problems paying its short term obligations.
ANRG's Quick ratio of 0.81 is on the low side compared to the rest of the industry. ANRG is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.81
ANRG.CA Yearly Current Assets VS Current LiabilitesANRG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 80.54% over the past year.
Looking at the last year, ANRG shows a small growth in Revenue. The Revenue has grown by 3.05% in the last year.
ANRG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.47% yearly.
EPS 1Y (TTM)80.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.82%
Revenue 1Y (TTM)3.05%
Revenue growth 3Y-4.2%
Revenue growth 5Y4.47%
Sales Q2Q%36.92%

3.2 Future

The Earnings Per Share is expected to grow by 27.24% on average over the next years. This is a very strong growth
Based on estimates for the next years, ANRG will show a very strong growth in Revenue. The Revenue will grow by 32.78% on average per year.
EPS Next Y52.38%
EPS Next 2Y27.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year42.04%
Revenue Next 2Y32.78%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ANRG.CA Yearly Revenue VS EstimatesANRG.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
ANRG.CA Yearly EPS VS EstimatesANRG.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5 -2 -2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ANRG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ANRG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ANRG.CA Price Earnings VS Forward Price EarningsANRG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ANRG.CA Per share dataANRG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6

4.3 Compensation for Growth

ANRG's earnings are expected to grow with 27.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.24%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ANRG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ANAERGIA INC-SUB VOTING SHR

TSX:ANRG (9/19/2025, 7:00:00 PM)

2.66

+0.04 (+1.53%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)N/A N/A
Inst Owners3.15%
Inst Owner ChangeN/A
Ins Owners24.21%
Ins Owner ChangeN/A
Market Cap511.81M
Analysts82.86
Price Target3.06 (15.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)46.78%
Min EPS beat(2)21.57%
Max EPS beat(2)71.99%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)4.66%
Min Revenue beat(2)-7.97%
Max Revenue beat(2)17.28%
Revenue beat(4)2
Avg Revenue beat(4)-6.91%
Min Revenue beat(4)-38.13%
Max Revenue beat(4)17.28%
Revenue beat(8)2
Avg Revenue beat(8)-18.78%
Revenue beat(12)3
Avg Revenue beat(12)-17.23%
Revenue beat(16)3
Avg Revenue beat(16)-18.46%
PT rev (1m)130.77%
PT rev (3m)130.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)20%
EPS NY rev (1m)0%
EPS NY rev (3m)50%
Revenue NQ rev (1m)6.06%
Revenue NQ rev (3m)6.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)16.37%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.26
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.21
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.62
BVpS-0.34
TBVpS-0.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.41%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.7%
FCFM N/A
ROA(3y)-30.26%
ROA(5y)-19.89%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.61%
GM growth 5Y-1.13%
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 136.89%
Cap/Sales 6.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.81
Altman-Z -2.13
F-Score4
WACC7.75%
ROIC/WACCN/A
Cap/Depr(3y)1470.76%
Cap/Depr(5y)2019.96%
Cap/Sales(3y)40.34%
Cap/Sales(5y)55.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.82%
EPS Next Y52.38%
EPS Next 2Y27.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.05%
Revenue growth 3Y-4.2%
Revenue growth 5Y4.47%
Sales Q2Q%36.92%
Revenue Next Year42.04%
Revenue Next 2Y32.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year64.29%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y85.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.21%
OCF growth 3YN/A
OCF growth 5YN/A